Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoclopramide versus ondansetron for nausea and vomiting during spinal anesthesia in elective cesarean section
IRCT20260425069157N1Phase 3Recruiting
- Sponsor
- Urmia University of Medical Sciences
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Nausea and Vomiting comparing Metoclopramide group with Ondansetron group (2 arms). Primary endpoint: nausea and vomiting. Started May 2026; status: recruiting.
02
Drugs
metoclopramideondansetron
03
Conditions
Nausea and Vomiting
Beyond the preview
Go deeper on IRCT20260425069157N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260425069157N1.